A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate

NCT01517802 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer
Metastatic Breast Cancer

Interventions

DRUG: Abiraterone acetate
DRUG: Prednisone

Sponsor

Janssen Research & Development, LLC